ArticleJournal of molecular graphics & modelling2022
Elucidating the binding mechanism of LPA species and analogs in an LPA
Huiqun Wang, Mengchu Li, Celsey M St Onge, Babette Fuss, Yan Zhang
Abstract read
In one paragraphArticle in Journal of molecular graphics & modelling, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 93% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
5 authors at 2 institutions in 1 country.
Huiqun WangDepartment of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, Richmond, VA, 23298, United States.
Mengchu LiDepartment of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, Richmond, VA, 23298, United States.
Celsey M St OngeDepartment of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, Richmond, VA, 23298, United States.
Babette FussDepartment of Anatomy and Neurobiology, Virginia Commonwealth University Medical Center, Richmond, VA, 23298, United States.
Yan ZhangDepartment of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, Richmond, VA, 23298, United States. Electronic address: yzhang2@vcu.edu.
Virginia Commonwealth University · USVirginia Commonwealth University Medical Center · US
Funding
Mu Opioid Receptor Modulator Development to Treat Opioid Use DisorderUH3DA050311 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI ZHANG, YAN · 2023 to 2025
$4.3MNon-peptide Mu Opioid Receptor Selective AntagonistsR01DA024022 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI ZHANG, YAN · 2009 to 2019
$3.5MNovel fentanyl derivatives as counteracting agents against fentanylUG3DA050311 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI ZHANG, YAN · 2019 to 2020
$2.2MDevelopment of a Potential Treatment for Polysubstance Use DisordersF31DA054796 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI ST. ONGE, CELSEY MACKENNA · 2021 to 2022
$80kNIDA NIH HHS F31 DA054796NIDA NIH HHS R01 DA024022NIDA NIH HHS UG3 DA050311NIDA NIH HHS UH3 DA050311
6 · The paper itselfAbstract
Lysophosphatidic acid receptor 4 (LPA
Indexed as
LysophospholipidsReceptors, Lysophosphatidic AcidLigandsLigandsLysophospholipidsReceptors, Lysophosphatidic AcidLPA speciesLysophosphatidic acid receptor 4 (LPA(4))Structure activity relationship via modeling
Identifiers
PMID35868118
PMCPMC13276977
OpenAlexW4285602695
What Socratic holds
Textmetadata
LicenceTDM
Read underepoch 390